Cavity obliteration is a procedure done at the end of Mastoidectomy to get a cavity-less mastoid cavity thus solving the problem of discharging post-operative cavity.
Lateral skull base anatomy and applied science by Dr, bomkar bamBomkar Bam
the lateral skull base is complex anatomy that is usually students finds difficult to understand. here concise literature is made to understand the skull base more easily.
Cavity obliteration is a procedure done at the end of Mastoidectomy to get a cavity-less mastoid cavity thus solving the problem of discharging post-operative cavity.
Lateral skull base anatomy and applied science by Dr, bomkar bamBomkar Bam
the lateral skull base is complex anatomy that is usually students finds difficult to understand. here concise literature is made to understand the skull base more easily.
Inner ear malformations and ImplantationUtkal Mishra
This slide vividly describes relevant anatomy & embryology of cochlea. It gives the reader insights into various cochlear malformations & implantation.
Spaces of middle ear and their surgical importanceDr Soumya Singh
one of the imp topics in ENT that should be understood very thoroughly if u want to pursue as an otologist.I tried to simplify the topic with simple diagrams and models for better understanding .
Inner ear malformations and ImplantationUtkal Mishra
This slide vividly describes relevant anatomy & embryology of cochlea. It gives the reader insights into various cochlear malformations & implantation.
Spaces of middle ear and their surgical importanceDr Soumya Singh
one of the imp topics in ENT that should be understood very thoroughly if u want to pursue as an otologist.I tried to simplify the topic with simple diagrams and models for better understanding .
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. Anatomy
• located at the posterolateral skull base
• long axis obliquely directed in the
posterolateral to anteromedial
• formed by the petrous temporal bone
anterolaterally and by the jugular process of
the condylar part of the occipital bone
posteromedially
3.
4.
5.
6.
7.
8. • The jugular foramen is traditionally divided
into a large posterolateral compartment (pars
venosa) and a smaller anteromedial
compartment (pars nervosa)
• three compartments: two venous
compartments and one neural intrajugular
compartment in between
9. • The venous compartments include a large
posterolateral sigmoid part and a small
anteromedial petrosal part.
• At the junction : two bony prominences
(intrajugular processes), arising from the
temporal and occipital bones: intrajugular
septum
10. • The dura over the intrajugular septum has two
characteristic perforations:
• (1) The glossopharyngeal meatus for the IX
nerve and
• (2) A larger vagal meatus for X and XI nerves
11.
12.
13. • The inferior petrosal sinus (IPS) joins the
jugular bulb in 90%, passing between the IX
nerve superolaterally and the X and XI nerves
inferomedially
• In 10% it drains directly into the internal
jugular vein
14. Condylar emissary vein
• The occipital condyle (OC) contains a condylar
emissary vein in 70% of cases.
• This posterior condylar vein enters the jugular
foramen at its posteromedial part and serves
as a landmark to the foramen for the posterior
approaches
• The hypoglossal canal contains a venous
plexus, called anterior condylar vein in
addition to the XII nerve
18. Classification of JF lesions
• Fisch’s and Glasscock and Jacobson’s
classification for glomus jugular tumours
• Keye’s and Franklin’s classification for
schwannoma.
• The one proposed by Bertalanffy and Ulrich is
applicable to any type of lesion
20. difficulties in exposing
• its deep location
• the carotid artery anteriorly,
• the facial nerve laterally,
• the hypoglossal nerve medially,
• The vertebral artery inferiorly,
23. SO retrosigmoid
• One component of more extensive exposure
• Main indication (intradural)
type A schwannoma, acoustic schwannoma
epidermoid cyst
• Intracranial part of JF exposed by dissecting
arachnoid around 9,10,11
• Disadv: extradural and intrajugular
24. Suboccipital Transcondylar
• More extended lateral and inferior exposure
Bony resection includes
• Post and medial occipital condyle
• Jugular tubercle to expose hypoglossal canal
• Jugular foramen dorsally and inferiorly (post
emissary vein landmark)
• Risk : Injury (VA, CN)
25. Supracondylar app
• Small lesion limited to hypoglossal canal and
medial rim of JF
• SOC extended down to supracondylar fossa
• OC and FM preserved
• Jugular tubercle drilled extradurally
• Disadv : radical resection not possible
26. Anterolateral Approach
• Postauricular transtemporal
• Preauricular subtemporal – infratemporal
approach
• The skin incision: pre- or retroauricular, and
starts above the level of the pinna
• extends in a curvilinear fashion inferiorly into
the neck superficial to the SCM
27.
28. Postauricular transtemporal
• Key component : mastoidectomy and neck
dissection
• Mastoidectomy : involve the intralabyrinthine
region with exposure of the sigmoid sinus,
jugular bulb, and mastoid portion of the facial
nerve
• Facial nerve mobilsed
• Rectus capitis lateralis ms detached
• Hearing does not sacrificed
29. Preauricular subtemporal –
infratemporal approach
• Preauricular incision across zygoma
• FT craniotomy
• Mobilisation of TM joint
• Middle cranial fossa removed , until carotid canal is
reached
• eustachian tube and tensor tympani muscle sacrificed
• removal styloid process allows anterior mobilization of
the internal carotid artery and access to the clivus.
• Drilling of Kawase's triangle gains access to the
posterior cranial fossa.
30. Fisch description
• Type A allows access to the temporal bone in
its infralabyrinthine and apical compartments
• Postauricular incision
• EAC transected
• Neck dissection : identification of CN , vessels
• Radical mastoidectomy and subtotal
petrosectomy
• Facial N anterior transposition
31. • Both middle and posterior cranial fossa dura in
front (Trautmann's triangle) and behind of the
sigmoid sinus are exposed.
• The petrous internal carotid artery is identified
and the eustachian tube is obliterated at its bony
isthmus.
• The mandibular condyle is resected, and the
temporal root of the zygoma and lateral orbital
rim are removed for additional exposure
34. Juxtacondylar app
• Extradural, confined to jugular F
• Incision : superior nuchal line to medial border
of SCM below mastoid
• Transverse process of atlas removed and VA
transposed
• PL aspect of OA and AA joint exposed
• Post belly of digastric resected and occipital
artery ligated
35. • Partial mastoidectomy done distal SS exposed
• Post inf wall of jugular bulb drilled to expose
JF
• Adv : wide exposure of post inf JF without
petrous drilling : preserves hearing
• Extradural : no csf leak
• Risk : VA injury , venous bleed
36. Lateral Skull base
• Conserving Otic capsule
infratemporal fossa type A
Petro Occipital Trans Sigmoid (POTS)
• Sacrificing Otic Capsule
Translabyrinthine
transcochlear
37. Infratemporal fossa type A
• Incision : post auricular extending superiorly
to temporal region
• Inferiorly along ant border of SCM
40. • VII CN freed from geniculate ganglion to
stylomastoid foramen and transposed
anteriorly
• Mandibular condyle is resected
• SS is packed or ligated
• Lateral wall of SS is opened to bulb and IPS
and entry of condylar vein packed
• ADV : wide exposure of anterior of JF till
petrous apex
41. Petro Occipital Trans Sigmoid
• Infralabyrinthine lateral skull base
• Indicated for :
• lower cranial nerve schwannomas with
intracranial extensions
• meningioma of the jugular bulb small
petroclival meningiomas lying anterio to the
internal auditory canal (IAC) with preserved
hearing.
42. • Technique: c shaped post auricular incision
• U shaped musculoperiosteal flap raised
• SCM retracted post
• IJV ant to lateral process of atlas identified &
ligated
• Radical mastoidectomy
• VII CN and JB identified
43. • Bone over SS and JB and posterior fossa dura
in front of the SS are removed
• suboccipital craniotomy
• The infralabyrinthine petrous bone is drilled
away taking care not to injure the posterior
semicircular canal or VII nerve.
• The occipital condyle is partially drilled up to
the hypoglossal canal
44. • SS is then opened and packed distally and
proximally
• A horizontal dural incision is made starting
posterior to the SS, coursing anteriorly traversing
the medial wall of the SS
• The removal of the lateral wall of the JB and, if
necessary, its medial wall, fully exposes the
intracranial part of IX−XI nerves.
• The dura over the drilled part of the OC is
excised exposing the hypoglossal canal
45. • ADV: hearing preserved
• Disadv: limited control over ICA , so
involovemet of ICA is contraindication